This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Central China New Life Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Central China New Life.

Wichtige Informationen

5.3%

Wachstumsrate der Gewinne

5.3%

EPS-Wachstumsrate

Real Estate Gewinnwachstum	13.1%
Wachstumsrate der Einnahmen	3.3%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	23 Aug 2023

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

SZSC:9983 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	4,050	732	381	974	3
12/31/2024	3,602	609	373	588	3
12/31/2023	3,214	47	17	601	3
12/31/2022	3,148	562	296	309	N/A
9/30/2022	3,374	606	687	82	N/A
6/30/2022	3,600	649	-184	-145	N/A
3/31/2022	3,600	634	-19	17	N/A
12/31/2021	3,599	620	1,408	178	N/A
9/30/2021	3,378	561	970	369	N/A
6/30/2021	3,157	503	532	560	N/A
3/31/2021	2,906	465	395	421	N/A
12/31/2020	2,654	427	257	281	N/A
9/30/2020	2,395	368	244	263	N/A
6/30/2020	2,136	310	231	245	N/A
3/31/2020	1,945	274	248	263	N/A
12/31/2019	1,754	239	266	281	N/A
12/31/2018	694	89	129	133	N/A
12/31/2017	461	66	80	84	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 9983's forecast earnings growth (5.3% per year) is above the savings rate (1.9%).

Ertrag vs. Markt: 9983's earnings (5.3% per year) are forecast to grow slower than the Hong Kong market (15.2% per year).

Hohe Wachstumserträge: 9983's earnings are forecast to grow, but not significantly.

Einnahmen vs. Markt: 9983's revenue (3.3% per year) is forecast to grow slower than the Hong Kong market (8.7% per year).

Hohe Wachstumseinnahmen: 9983's revenue (3.3% per year) is forecast to grow slower than 20% per year.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Insufficient data to determine if 9983's Return on Equity is forecast to be high in 3 years time

This company listing is no longer active

Central China New Life Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Central China New Life Limited Provides Earnings Guidance for the Six Months Ended June 30, 2021

Recent updates

Central China New Life Limited Declares Interim Dividend for the Six Months Ended 30 June 2023, Payable on 20 December 2023

Central China New Life Limited to Report First Half, 2023 Results on Aug 21, 2023

Now 20% undervalued

Now 22% undervalued after recent price drop

Central China New Life Limited Approves Final Dividend for the Year Ended 31 December 2022

Upcoming dividend of HK$0.19 per share at 14% yield

Now 23% undervalued after recent price drop

Less than half of directors are independent

Less than half of directors are independent

Central China New Life Limited Announces Board Changes

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Central China New Life Limited Proposes Interim Dividend for the Six Months Ended 30 June 2022, Payable on 03 October 2022

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.21 per share

Central China New Life Limited Proposes Interim Dividend for the Six Months Ended 30 June 2022

Central China New Life Limited to Report First Half, 2022 Results on Aug 22, 2022

Investor sentiment improved over the past week

Central China New Life Limited Approves Final Dividend for the Year Ended 31 December 2021, Payable on 25 May 2022

Upcoming dividend of HK$0.34 per share

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Company Secretary Yee Man To has left the company

Upcoming dividend of HK$0.14 per share

Investor sentiment deteriorated over the past week

Central China New Life Limited Provides Earnings Guidance for the Six Months Ended June 30, 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Central China New Life Limited Approves Final Dividend for the Year Ended December 31, 2020

COO & Executive Director has left the company

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.27 in FY 2019)

Central China New Life Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day low: HK$6.02

New 90-day high: HK$7.90

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: HK$6.05

Insider recently bought HK$4.9m worth of stock

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken